US Airways Group Inc. said Monday that its March traffic dipped 0.1 percent from a year earlier, but another importantair Shox R3 Ordinary measure — per-passenger revenue — rose sharply, a sign the airline industry is recovering from a deep slump. The airline said its passenger revenue per available seat mile — one seat flown one mile — rose about 18 percent from March 2009, including regional flights.air Shox R4 Fangle Continental Airlines said last week that its passenger unit revenue in March rose about 15 percent. Both airlines, along with American and AirTran,air Shox R4 Kid also reported gains in traffic compared with a year ago. US Airways said paying passengers flew 5.08 billion miles last month, down from 5.09 billion miles inair Shox R4 Large Hook March 2009. Capacity fell 1.8 percent, to 6.15 billion available seat miles. Airlines reduce capacity by operating fewer air Shox R4 Lineflights or using smaller planes. Flights were more full. Average occupancy rose to 82.6 percent in March, up from 81.3 percent air Shox R4 Men Shoesa year ago. The figures included both the mainline US Airways brand andair Shox R4 Mesh its regional operations, US Airways Express. Scott Kirby, the company president, said US Airways was air Shox R4 Perforationalso seeing strong growth in revenue per mile based on prices customers pay. After being battered the past two years by high fuel prices air Shox R4 Platingand a recession that hurt travel, airlines hope to return to profitability this year. For the full first quarter, US Airways said traffic fell 2 percent, toair Shox R4 PU 13.51 billion miles flown by paying customers. air Shox R4 Plating Air CushionCapacity was cut a slightly larger 2.6 percent, boosting average occupancy to 78.2 percent from 77.7 percent a year earlier. US Airways shares fell 27 cents, or 3.7 percent, to close atair Shox R4 Transparent Fundus $7.13. The medical device-maker agreed to plead guilty to two misdemeanors for excluding defibrillator-malfunctionair Shox R4 Three Age reports from product updates sent to doctors and failing to alert the U.S. Food and Drug Administration to the defects. Prosecutors said in court papers that Guidant officials learned as air Shox R5 Girl Kidearly as 2002 that some of the defibrillators had short-circuiting problemsair Shox R4 Women Shoes that led to some users’ deaths. The company didn’t disclose the defects for more than three years, the government added in the filings. Sales Halted Last month, Boston Scientific halted all sales of heart- rhythm devices because of an erroneous filing with regulators. “When a corporation who makes life-saving devices lies to the FDA,Air Max 95 that puts the implantees and others at risk,” Charles Zimmerman, an attorney for plaintiffs, said during today’s hearing. “Today Guidant comes before the court and asks you to accept a plea of guilty in which they admit they have lied.” Paul Donovan, a Boston Scientific spokesman, had no immediate comment. Boston Scientific, the world’s second-largest maker of heart devices, is cutting as many as 1,300 jobs, or 10 percent of its non-manufacturing workforce, because it expects sales growth for drug-coated stents and heart defibrillators will slow this year. Minneapolis-based Medtronic Inc. is the world’s largest maker of heart-rhythm devices. Natick, Massachusetts-based Boston Scientific will close its international headquarters, merge the endosurgery group and combine its cardiovascular and cardiac rhythm-management groups, the company said in a Feb. 10 statement. The move will reduce expenses by as much as 7 percent, or $250 million, over the next two years, Boston Scientific officials said. Shares Plunge Boston Scientific’s shares fell the most in 17 months on March 15 after the company said it stopped sales of defibrillators because of a documentation error. The devices brought in $1.79 billion last year, or 22 percent of Boston Scientific’s revenue, according to data compiled by Bloomberg.